Aurora Cannabis (ACB) Share-based Compensation (2017 - 2025)

Aurora Cannabis (ACB) posted quarterly Share-based Compensation of $1.7 million for Q1 2025, down 26.21% year-on-year from $2.2 million in Q1 2024, and up 39.83% on a QoQ basis from $1.2 million in Q4 2024.

Aurora Cannabis (ACB) Share-based Compensation (2017 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has reported Share-based Compensation for 9 consecutive years, with $1.7 million the latest figure, recorded in Q1 2025.

  • Quarterly Share-based Compensation fell 26.21% year-over-year to $1.7 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $8.3 million (down 46.49% YoY) and the FY2026 annual result came in at $5.3 million, down 36.34% from the prior year.
  • Share-based Compensation rose to $1.7 million in Q1 2025 per ACB's latest filing, from $1.2 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ACB reached as high as $7.8 million in Q4 2022 and fell as low as $1.2 million in Q4 2024.
  • A 5-year average of $3.0 million and a median of $2.7 million in 2022 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2022 — Share-based Compensation surged 153.81% — and 2023, when it plunged 73.34%.
  • Year by year, Share-based Compensation stood at $3.1 million in 2021, then jumped by 153.81% to $7.8 million in 2022, then tumbled by 73.34% to $2.1 million in 2023, then tumbled by 43.12% to $1.2 million in 2024, then soared by 39.83% to $1.7 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $1.7 million, $1.2 million, and $3.3 million for Q1 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.66 Mn
Mar 31, 2025 1.66 Mn
Dec 31, 2024 1.19 Mn
Dec 31, 2024 1.19 Mn
Sep 30, 2024 3.28 Mn
Sep 30, 2024 3.28 Mn
Jun 30, 2024 2.21 Mn
Jun 30, 2024 2.21 Mn
Mar 31, 2024 2.25 Mn
Mar 31, 2024 2.25 Mn
Dec 31, 2023 2.09 Mn
Dec 31, 2023 2.09 Mn
Sep 30, 2023 3.41 Mn
Sep 30, 2023 3.41 Mn
Dec 31, 2022 7.82 Mn
Dec 31, 2022 7.82 Mn
Sep 30, 2022 4.86 Mn
Sep 30, 2022 4.86 Mn
Jun 30, 2022 2.72 Mn
Jun 30, 2022 2.72 Mn